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Abstract
Introduction We aimed to investigate the characteristics
and outcome of patients suffering early major worsening
(EMW) after acute ischemic stroke (AIS) and assess the
parameters associated with it.
Methods All consecutive patients with AIS in the
ASTRAL registry until 10/2010 were included. EMW was
defined as an NIHSS increase of C8 points within the first
24 h after admission. The Bootstrap version of the Kol-
mogorov–Smirnov test and the v2-test were used for the
comparison of continuous and categorical covariates,
respectively, between patients with and without EMW.
Multiple logistic regression analysis was performed to
identify independent predictors of EMW.
Results Among 2155 patients, 43 (2.0 %) had an EMW.
EMW was independently associated with hemorrhagic
transformation (OR 22.6, 95 % CI 9.4–54.2), cervical
artery dissection (OR 9.5, 95 % CI 4.4–20.6), initial dys-
arthria (OR 3.7, 95 % CI 1.7–8.0), and intravenous
thrombolysis (OR 2.1, 95 % CI 1.1–4.3), whereas a nega-
tive association was identified with initial eye deviation
(OR 0.4, 95 % CI 0.2–0.9). Favorable outcome at 3 and
12 months was less frequent in patients with EMW com-
pared to patients without (11.6 vs. 55.3 % and 16.3 vs.
50.7 %, respectively), and case fatality was higher (53.5 vs.
12.9 % and 55.8 vs. 16.8 %, respectively). Stroke recur-
rence within 3 months in surviving patients was similar
between patients with and without EMW (9.3 vs. 9.0 %,
respectively).
Conclusions Worsening of C8 points in the NIHSS score
during the first 24 h in AIS patients is related to cervical
artery dissection and hemorrhagic transformation. It justi-
fies urgent repeat parenchymal and arterial imaging. Both
conditions may be influenced by targeted interventions in
the acute phase of stroke.
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Introduction
Several terms have been used to describe neurological
deterioration during the acute phase in patients with
ischemic stroke such as ‘‘stroke-in-evolution’’, stroke-in-
progress,’’ and ‘‘stroke progression’’. The underlying
mechanism may involve either additional brain insults
(e.g., ischemic stroke recurrence, hemorrhagic transfor-
mation, edema, elevated intracranial pressure, epileptic
seizure) or systemic derangements like hypoglycemia,
hyponatremia, infection, hypoxemia, and hypotension [1].
Early neurological deterioration is not an uncommon
condition: the reported incidence ranges between 26 and
43 % [2–6]. This wide range of estimate is explained by
the various definitions used to describe worsening involv-
ing different stroke scales, different cut-offs, e.g., increase
of the former scale by C2 or C4 points, and different
timeframes, e.g., from 24 h to 7 days after stroke onset [1].
We were interested in severe, or ‘‘major’’ worsening using
a threshold of C8 points in the National Institute of Health
Stroke (NIHSS) because predictors of milder worsening are
already described [6–9], and a higher limit may be
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clinically more meaningful, more specific to identify
worsening, and less rater-dependent [1].
Furthermore, limiting this analysis to a narrow time
frame when worsening occurs may increase the chances
that interventions to correct it may limit its unfavorable
effects. To our knowledge, no study has investigated the
predictors of early major worsening (EMW) during the
acute phase of stroke.
The aim of the present study was to investigate the
characteristics and outcome of acute ischemic stroke (AIS)
patients suffering an early (within 24 h) major (defined as
C8 point NIHSS increase) worsening and assess the
parameters associated with it.
Methods
All consecutive patients admitted to the stroke unit or
intensive care unit of the Centre Hospitalier Universitaire
Vaudois (CHUV) between 01/2003 and 10/2010 with a
main diagnosis of AIS within 24 h after last proof of being
well were included in the analysis. All patients were pro-
spectively registered in the Acute STroke Registry and
Analysis of Lausanne (ASTRAL) [10]; the scientific use of
the data registered in ASTRAL was approved by the ethics
commission for research on humans of the Canton of Vaud.
The methods applied to collect and register data, and the
definitions used in ASTRAL were previously described [10].
In summary, a large range of parameters are prospectively
registered: demographics (age, gender, ethnicity), medical
history, and cardiovascular risk factors (prestroke modified
Rankin score, previous stroke or transient ischemic attack or
retinal ischemia, hypertension, diabetes mellitus, dyslipi-
demia, smoking, atrial fibrillation, coronary artery disease,
valvulopathy, low ejection fraction, peripheral artery dis-
ease, body-mass-index) current medication (antiplatelets,
anticoagulants, antihypertensives, lipid-lowering drugs,
hormones, antidiabetics), vital signs (blood pressure, tem-
perature, heart rate), clinical symptoms and examination
(i.e., paresis, dysarthria, sensory deficit, visual fields defect,
eye deviation, oculomotor brainstem symptoms, cerebellar,
ataxic or vestibular signs, aphasia, neglect, level of vigi-
lance), features and severity of the stroke (affected side,
vascular territory, brain structures affected, cortical versus
subcortical involvement, NIHSS score at admission and
at 24 h), and treatment (thrombolysis, onset-to-treatment
time). Patients who died within 24 h were assigned a NIHSS
of 42 at 24 h. Vital signs (skin temperature, blood pressure,
heart rate) and metabolic and hematologic parameters (glu-
cose, creatinine, total cholesterol, white blood cells,
hematocrit, platelets) were measured at admission (usually
in the emergency room) and at 24–48 h after admission.
Findings from acute brain imaging on admission (visibility
of the acute ischemic lesion, early hemorrhagic transfor-
mation, hyperdense middle cerebral artery sign, chronic
stroke lesions, leukoaraiosis, mostly on CT scans) and acute
arterial imaging (arterial stenosis C50 % or occlusion, cer-
vical artery dissection, recanalization status; mostly on CT-
angiography) were also registered. Stroke pathophysiology
was classified according to the TOAST classification [11],
but arterial dissections and multiple causes were separately
noted. A majority of the patients with initial arterial occlu-
sion also had repeat arterial imaging (CT-angiography, MR-
angiography, or Doppler) at 24–48 to assess recanalization
status. Patients with clinical worsening by C2 NIHSS points
during the hospital stay usually underwent repeat brain and
arterial imaging. Symptomatic intracranial hemorrhage was
defined according to ECASS-II [12].
EMW was defined as an increase of the NIHSS score at
24 h after admission of C8 points compared to the NIHSS
score at admission. Death within 24 h was also considered
as EMW. Unfavorable clinical outcome was defined as
modified Rankin Scale score (mRS) >2 at 3 and
12 months and was assessed in the outpatient clinic or on a
structured telephone interview by mRS certified personnel.
Furthermore, stroke recurrence and mortality were assessed
also at 12 months with the same method.
Statistical Analysis
Associations between the above mentioned clinical and
paraclinical variables with EMW were first investigated.
Continuous covariates are summarized as median and
interquartile range (IQR), and categorical covariates as
absolute values and percentage (%). The bootstrap version
of the Kolmogorov–Smirnov test and the v2-test were used
for the comparison of continuous and categorical covari-
ates, respectively, between patients with and without
EMW, in the univariate analysis. Backward elimination
procedure was applied on the multiple logistic regression
model of the complete cases, to determine the significant
covariates at 5 % significance level. An imputation process
was implemented on the set of the significant independent
predictors of EMW (5 imputed datasets), and the final
inference was derived by appropriately combining the
inferences of the imputed analyses. Statistical analysis was
performed with R 2-13-1.
Results
Among 2209 AIS registered in ASTRAL between January
2003 and October 2010, 54 (2.4 %) were excluded due to
missing NIHSS score either at admission or at 24 h later.
Among the remaining 2155 AIS, 43 (2.0 %) had an EMW
at 24 h after admission, of whom 23 (53.5 %) died within
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3 months. The cause of death was severe ischemic stroke in
12 (52.2 %) patients, hemorrhagic transformation in 5
(21.7 %) patients, post-stroke infection in 3 (13.0 %)
patients and acute decompensated heart failure in 2 (8.7 %)
patients. The baseline characteristics of patients with and
without EMW are summarized in Table 1. None among
patients with lacunar stroke suffered an EMW. Repeat
arterial imaging at 24–48 h was performed in 773 (35.0 %)
patients. There was 1 (2.3 %) protocol deviation [i.e.,
thrombolysis later than 180 min after stroke onset (or
270 min after 2008)] in the group with early major wors-
ening, and 16 (0.8 %) in the group of patients without early
major worsening.
In multiple logistic regression analysis, EMW was inde-
pendently associated with hemorrhagic transformation,
cervical artery dissection, admission dysarthria, and intrave-
nous thrombolysis, whereas a negative association was
identified with eye deviation on initial examination (Table 2).
Favorable outcome at 3 and 12 months was less frequent
in patients with EMW compared to patients without
(Table 3). In similar, case fatality at 3 and 12 months were
higher in patients with EMW. Stroke recurrence within
3 months was similar between patients with and without
EMW.
Discussion
The present study investigated the predictors and outcome
of EMW in a large series of patients with of AIS. We found
that hemorrhagic transformation, cervical artery dissection,
admission dysarthria, and intravenous thrombolysis were
associated with major worsening, whereas there was an
inverse association with eye deviation. As expected,
unfavorable outcome was more frequent in patients with
EMW compared to patients without.
Table 1 Patient characteristics
NS non-significant
a Defined as occlusion
or >50 % stenosis
With early
major worsening
(n = 43)
Without early
major worsening
(n = 2,112)
p value
Age (years) 67.4 ± 23.9 72.7 ± 21.0 n.s.
Male sex 19 (44.2 %) 1,187 (56.2 %) n.s.
Onset-to-admission time (min) 174 ± 138 222 ± 594 <0.01
NIHSS score at admission 10.0 ± 10.0 6.0 ± 11.0 <0.01
NIHSS score at 24 h after admission 24.0 ± 15.0 4.0 ± 9.0 <0.01
Dysarthria 33 (76.7 %) 953 (45.1 %) <0.01
Eye deviation 11 (25.6 %) 418 (19.8 %) n.s.
Systolic blood pressure at admission (mmHg) 151.0 ± 35.0 157.0 ± 35.5 n.s.
Subacute systolic blood pressure (mmHg) 151.0 ± 25.8 140.0 ± 27.0 <0.01
Glucose at admission (mmol/l) 6.9 ± 3.0 6.5 ± 2.1 n.s.
Subacute glucose (mmol/l) 6.4 ± 2.5 5.7 ± 1.6 <0.01
Stroke mechanism
Large-artery atherosclerosis 7 (16.3 %) 282 (13.4 %) n.s.
Cardioembolic 10 (23.3 %) 692 (32.8 %) n.s.
Lacunar 0 (0.0 %) 310 (14.7 %) <0.05
Arterial dissection 10 (23.3 %) 90 (4.3 %) <0.01
Multiple/coexisting/other defined 5 (11.6 %) 189 (8.9 %) n.s.
Unknown 11 (25.6 %) 521 (24.7 %) n.s.
Arterial territory
Anterior circulation 36 (83.7 %) 1,294 (61.3 %) <0.01
Posterior circulation 6 (14.0 %) 608 (28.8 %) <0.05
Acute CT/MRI lesion at admission 23 (53.5 %) 729 (34.5 %) <0.05
Significant arterial pathologya 33 (76.7 %) 968 (45.8 %) <0.01
Intravenous thrombolysis 14 (32.6 %) 355 (16.8 %) <0.05
Complete arterial recanalisation 2 (4.7 %) 147 (7.0 %) n.s.
Partial or no arterial recanalisation 23 (53.5 %) 538 (25.5 %) <0.01
Hemorrhagic transformation 9 (20.9 %) 28 (1.3 %) <0.01
Of which thrombolysed/endovascular treatment 4 (44.4 %) 10 (35.7 %) n.s.
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Neurologic deterioration in the acute phase of stroke
may be caused by additional brain damage (e.g., new
stroke, hemorrhagic transformation, brain edema, seizures)
or by non-neurological factors (e.g., infection, metabolic
derangement like hypo/hyperglycemia and hypo/hyperna-
tremia, hemodynamic insufficiency) [1]. Hence, the
knowledge of the parameters which are associated with
deterioration is important. Several authors studied the
characteristics and outcomes in such patients. The defini-
tion of worsening used in these studies varied considerably
with regards to the scale, the time frame and the magnitude
of deterioration used to define it: Kwan et al. [6] defined
early neurological deterioration as an increase of the NI-
HSS score by C2 points (or stroke-related death) between
admission and day 5. Leigh et al. [8] defined hyperacute
clinical worsening as an increase of the NIHSS by C4
points during the first 24 h. The ECASS I group defined
early progression as a decrease by C2 points of con-
sciousness or motor power or a decrease by C3 points of
the speech score in the Scandinavian Stroke Scale during
the first 24 h [7]. Tei et al. [9] defined early neurological
deterioration as a decrease of C1 points in the Canadian
Neurological Scale in total, partial anterior or posterior
circulation infarcts, or an increase of C1 points in the
modified Rankin Scale score in lacunar infarcts during the
7 first days after stroke. The advantage of the conservative
definitions (i.e., small cut-offs for the increase in the NI-
HSS scale) is the earlier identification and, potentially,
timely treatment of the precipitating factor [1]. On the
contrary, more liberal definitions (i.e., larger cut-offs for
the increase in the NIHSS scale) are more specific to
identify worsening and likely more clinically relevant [1].
The present study differs from previous ones in that the
definition of clinical deterioration deliberately uses a high
cut-off (C8 points difference in the NIHSS scale).
Several parameters such as blood glucose, diabetes melli-
tus, blood pressure, body temperature, fibrinogen, and transient
ischemic attack were identified as predictors of early neuro-
logical deterioration in previous studies [1]. Obviously, the
variability of the results between these studies may be attrib-
uted to the difference in the definitions used to describe it. In
the present study, hemorrhagic transformation was the stron-
gest predictor of EMW. The fact that this parameter remained
significant after adjustment for thrombolytic treatment shows
that hemorrhagic transformation (either post-thrombolytic, as
in 32.6 % of our patients with EMW, or spontaneous) is
associated with EMW. It also emphasizes the need for better
identification of patients at high risk for hemorrhagic trans-
formation [13], for thrombolytic agents with less hemorrhage
risk and avoidance of early anticoagulation [14] .
Cervical artery dissection is also strongly associated
with EMW and emphasizes the potential danger of this
disorder. Early worsening could be due to the very dynamic
changes in acutely dissected cervical arteries, where rapid
changes in diameter lumen in the early phase may lead to
occlusion and worsening in a subset of patients. These
results implicate that urgent parenchymal and arterial
imaging should be performed in patients with EMW to
identify the presence of any of these two conditions, i.e.
hemorrhagic transformation and cervical artery dissection.
It may also suggest that arterial imaging should be per-
formed immediately at admission in order to identify
patients with cervical artery dissection. An independent
association of intravenous thrombolysis with recombinant
Table 2 Predictors of early
major worsening in patients
with acute ischemic stroke
OR odds-ratio, CI confidence
intervals
OR 95 % CI p value
Hemorrhagic transformation 22.6 9.4–54.2 <0.0001
Cervical artery dissection 9.5 4.4–20.6 <0.0001
Dysarthria 3.7 1.7–8.0 <0.001
Intravenous thrombolysis 2.1 1.1–4.3 0.03
Eye deviation 0.4 0.2–0.9 0.02
Table 3 Stroke outcome in
patients with and without early
major worsening
a Defined as modified Rankin
Scale score 0–2
With early
major worsening
(n = 43)
Without early
major worsening
(n = 2,112)
Craniectomy 2 (4.6 %) 15 (0.7 %)
3-months favorable outcomea 5 (11.6 %) 1,167 (55.3 %)
12-months favorable outcomea 7 (16.3 %) 1,070 (50.7 %)
3-months case fatality 23 (53.5 %) 272 (12.9 %)
12-months case fatality 24 (55.8 %) 354 (16.8 %)
Any stroke recurrence within 3 months
(ischemic or hemorrhagic)
4 (9.3 %) 190 (9.0 %)
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tissue plasminogen activator (rtPA) with EMW was also
identified, in addition to hemorrhagic transformation. As a
hypothesis to explain this, neurotoxic effects of rtPA [15]
may occur in certain individuals, as recently suggested in a
retrospective analysis of patients with acute stroke related
seizures [16]. Given, the overwhelming evidence of the
positive overall effect of thrombolysis in the majority of
patients, our findings should not constitute an argument
against this treatment in any patient who is eligible for it.
Initial dysarthria was also independently associated with
EMW, but eye deviation was inversely associated with
EMW. The pathophysiological explanation for these find-
ings remains unclear, but the latter finding was associated
with early neurological improvement in two previous
reports [17, 18]. We did not find cerebral edema with mass
effect to be associated with EMW, but this may be due to
the fact that the time peak of such worsening often occurs
more than 24 h after admission.
The strength of this study is the large number of pro-
spectively registered, consecutive patients with AIS. Also,
a wide set of demographic, clinical, laboratory, parenchy-
mal, and arterial imaging parameters were investigated,
using pre-specified definitions. Moreover, the delay
between stroke onset and admission was short (median of
174 min) which means that the NIHSS score measured at
admission probably represents a close proximate to the
actual NIHSS score at the time of stroke onset. Further-
more, we chose to investigate the predictors of major
worsening using a narrow time frame (i.e., 24 h after
admission), which is still early in the course of stroke and
may allow for timely therapeutic interventions.
On the limitations side of the study, although the dataset
is derived from a prospective stroke registry, the analysis is
retrospective, and therefore may be subject to bias. Also,
this is a single center study and the conclusions need to be
confirmed in other populations. Finally, there may be
potential unmeasured confounders such as nosocomial
infection; however, this is not expected to be clinically
evident so early (i.e., within the first 24 h after admission).
In conclusion, hemorrhagic transformation and cervical
artery dissection are strongly associated with EMW in patients
with AIS. In patients with an increase of C8 points in the
NIHSS score during the first 24 h after stroke, urgent paren-
chymal, and arterial imaging should be performed to exclude
hemorrhagic transformation and cervical artery dissection.
Conclusion
Hemorrhagic transformation and cervical artery dissection
are strongly associated with EMW in patients with AIS.
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